Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
71,085,776
-
Total 13F shares
-
30,695,789
-
Share change
-
+30,695,789
-
Total reported value
-
$601,183,000
-
Price per share
-
$19.86
-
Number of holders
-
45
-
Value change
-
+$601,183,000
-
Number of buys
-
45
Institutional Holders of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) as of Q4 2021
As of 31 Dec 2021,
Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,695,789 shares.
The largest 10 holders included
venBio Partners LLC, Third Point LLC, CITADEL ADVISORS LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Logos Global Management LP, Vivo Capital, LLC, RTW INVESTMENTS, LP, EcoR1 Capital, LLC, and ORBIMED ADVISORS LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.